|Scott Wolchko||President and CEO|
|Wayne Chu||SVP, Clinical development|
|Mike Ulz||Morgan Stanley|
|Srikripa Devarakonda||Truist Securities|
|Nick Abbott||Wells Fargo|
|Ted Tenthoff||Piper Sandler|
|Rob Burns||H.C. Wainwright|
Welcome to the Fate Therapeutics Third Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. This call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.